Overview of U.S. National Cancer Institute (USNCI) Chemoprevention Research

References

• Greenwald P, Kelloff G. The chemoprevention of cancer. Accomplishments in cancer research: 1992 prize year, J G Fortner, J E Rhoads. J.B. Lippincott, Philadelphia 1993; 242–65
   Google Scholar
• Greenwald P. Micronutrients and chemoprevention. Cancer: Principles and practice of oncology, V T De-Vita, S Hellman, S A Rosenberg. J.B. Lippincott, Philadelphia 1993; 457–63
   Google Scholar
• Malone W, Kelloff G, Boone C. Ongoing preclinical and initial clinical studies in chemoprevention. Chemoimmuno prevention of cancer, U Pastorino, W K Hong. Thieme Medical Publishers, Inc., New York 1991; 111–23
   Google Scholar
• Rogers A E, Longnecker M B. Biology of disease: Dietary and nutritional influence on cancer—A review of epidemiologic and experimental data. Lab Invest 1988; 59: 729–52
   PubMed Web of Science ®Google Scholar
• Carroll K K, Khor H T. Dietary fat in relation to tumorigene-sis. Progr Biochem Pharmacol 1975; 10: 308–53
   PubMedGoogle Scholar
• Parkin D M. Cancers of the breast, endometrium and ovary: Geographic correlations. Eur J Cancer Clin Oncol 1989; 25: 1917–25
   PubMedGoogle Scholar
• Dunn J. Breast cancer among American Japanese in the San Francisco Bay Area. Natl Cancer Inst Monogr 1977; 47: 157–60
   PubMedGoogle Scholar
• Prentice R L, Thompson D, Clifford C, Gorbach S, Goldin S, Byar D. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. J Natl Cancer Inst 1990; 82: 129–34
   PubMedGoogle Scholar
• Pike M C, Kraila M D, Henderson B E, Casagrande J T, Hoel D G. ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 1983; 303: 767–70
   PubMed Web of Science ®Google Scholar
• Kampert J B, Whittemore A S, Paffenbarger R S. Combined effect of childbearing, menstrual events and body size on age-specific breast cancer risk. Am J Epidemiol 1988; 128: 962–79
   PubMedGoogle Scholar
• Whittemore A S, Henderson B E. Dietary fat and breast cancer: Where are we?. J Natl Cancer Inst 1993; 85: 762–3
   PubMedGoogle Scholar
• Freedman L S, Prentice R L, Clifford C, Harlan W, Henderson M, Rossouw J. Dietary fat and breast cancer: Where we are. J Natl Cancer Inst 1993; 85: 764–5
   Google Scholar
• Henderson B E, Ross R, Bernstein L. Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1988; 48: 246–53
   PubMed Web of Science ®Google Scholar
• Harlan L C, Coates R J, Block G. Estrogen receptor status and dietary intakes in breast cancer patients. Epidemiol 1993; 4: 25–31
   PubMed Web of Science ®Google Scholar
• Rose D P, Boyar A P, Wynder E L. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer 1986; 58: 2363–71
   PubMed Web of Science ®Google Scholar
• Petrow V. The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications. Prostate 1986; 9: 343–61
   PubMed Web of Science ®Google Scholar
• Ross R K, Bernstein L, Lobo R A. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992; 339: 887–9
   PubMed Web of Science ®Google Scholar
• King M-C, Rowell S, Love S M. Inherited breast and ovarian cancer. JAMA 1993; 269: 1975–80
   PubMed Web of Science ®Google Scholar
• Malkin D, Li F P, Strong L C. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233–8
   PubMed Web of Science ®Google Scholar
• Swift M, Morrell D, Massey R, Chase C L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831–6
   PubMed Web of Science ®Google Scholar
• Hall J M, Lee M K, Newman B. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9
   PubMed Web of Science ®Google Scholar
• Natali P G, Nicotra M R, Bigotte A. Expression of the p185 oncogene in normal and transformed human tissues. Int J Cancer 1990; 45: 457–61
   PubMed Web of Science ®Google Scholar
• Lodato R F, Maguire H C, Greene M E, Weiner D B, LiVolsi V A. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Modern Pathology 1990; 3: 449–54
   PubMed Web of Science ®Google Scholar
• Steeg P S, Bevilacqua G, Kopper L. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200–4
   PubMed Web of Science ®Google Scholar
• Cohen L A, Kendall M E, Zang E, Meschter C, Rose D P. Modulation of N-nitrosomethylurea-induced mammary tumor promotion by dietary fiber and fat. J Natl Cancer Inst 1991; 83: 496–501
   PubMedGoogle Scholar
• Simon R. Evaluating the differential effect of diet on rat carcinogenesis. J Natl Cancer Inst 1991; 83: 1261–2
   Google Scholar
• Arts C JM, Van Den Berg H, Thijssen J HH. Effects of dietary fiber on N-nitrosomethylurea-induce mammary tumors and on plasma estrogen levels in rats. J Natl Cancer Inst 1991; 83: 1347–8
   Google Scholar
• Ratko T A, Detrisac C J, Dinger N M, Thomas C F, Kelloff G J, Moon R C. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res 1989; 49: 4472–6
   PubMed Web of Science ®Google Scholar
• Kelloff G J, Boone C W, Malone W F, Steele V E. Chemoprevention clinnical trials. Mutation Res 1992; 267: 291–5
   Google Scholar
• Kramer B S, Brawley O W, Nayfield S, Johnson K, Greenwald P, Ford L G. NCI studies in primary prevention of breast and prostate cancer. Cancer Res Ther Control 1993; 3: 203–11
   Google Scholar
• Redmond C K, Wickerham D L, Cronin W, Fisher B, Costantino J, NSABP Participants. The NSABP Breast Cancer Prevention Trial (BCPT): A progress report. Proc ASCO 1993; 12(78)69
   Google Scholar
• Nayfield S G, Karp J E, Ford L G, Dorr A, Kramer B S. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991; 83: 1450–9
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1–15
   PubMed Web of Science ®Google Scholar
• Love R R, Mazess R B, Barden H S. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992; 326: 852–6
   PubMed Web of Science ®Google Scholar
• Love R R, Wiebe D A, Newcomb P A. Effects of tamox-ifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 1991; 115: 860–4
   PubMed Web of Science ®Google Scholar
• Gormley G J, Stoner E, Bruskewitz R C. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992; 327: 1185–91
   PubMed Web of Science ®Google Scholar
• Omenn G S. A double-blind randomized trial with beta-carotene and retinol in persons at high risk of lung cancer due to occupational asbestos exposures and/or cigarette smoking. Public Health Rev 1988; 16: 99–125
   PubMedGoogle Scholar
• Taylor P R, Dawsey S D, Albanes D. Cancer prevention trials in China and Finland. Ann Epidemiol 1990; 1: 195–203
   Google Scholar
• Hennekens C H, Eberlein K A. A randomized trial of aspirin and beta-carotene among U.S. physicians. Prev Med 1985; 14: 165–8
   PubMed Web of Science ®Google Scholar
• The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989; 321: 129–35
   PubMed Web of Science ®Google Scholar
• Gann P H, Manson J E, Glynn R J, Buring J E, Hennekens C H. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993; 1220–4
   Google Scholar
• Women's Health Study Research Group. The women's health study: Summary of the study design. J Myocardial Ischemia 1992; 4: 27–9
   Google Scholar
• Women's Health Study Research Group. The women's health study: Background and rationale. J Myocardial Ischemia 1992; 4: 30–40
   Google Scholar
• Yang C S, Sun Y, Yang Q. Vitamin A and other deficients in Linxian, a high esophageal cancer incidence area in Northern China. J Natl Cancer Inst 1984; 73: 1449–53
   PubMed Web of Science ®Google Scholar
• Blot W J, Li J-Y, Taylor P R. Nutrition intervention trials in Linxian China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483–92
   PubMed Web of Science ®Google Scholar